RNAi-mediated knockdown of α-enolase increases the sensitivity of tumor cells to antitubulin chemotherapeutics

International Journal of Biochemistry and Molecular Biology

Volumn 2, Issue 4, 2011, Pages 303-308

  Georges, Elias ^a   Bonneau, Anne Marie ^a,b   Prinos, Panagiotis ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b AnexChem Inc   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

enolase; A549; Antitubulin chemotherapeutics; Cancer; CaOV3; Chemotherapeutic drugs; H460 lung; Knockdown; MCF7 breast; Rnai; Sensitivity

Indexed keywords

ALPHA ENOLASE; ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; MITOXANTRONE; PACLITAXEL; VINBLASTINE; VINCRISTINE;

ANAEROBIC GLYCOLYSIS; ARTICLE; CANCER CELL; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DOWN REGULATION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IC 50; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RNA INTERFERENCE; SENSITIVITY ANALYSIS; UPREGULATION;

EID: 84855939630     PISSN: None     EISSN: 21524114     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kim JW, Dang CV. Multifaceted roles of glycolytic enzymes. Trends Biochem Sci 2005; 30: 142-150.
2. IN, D. Enolases and PGP9.5 as tissue-specific markers. Biochem Soc Trans 1992; 20: 637-642.
3. Villar-Palasi C, Larner J. Glycogen metabolism and glycolytic enzymes. Annu Rev Biochem 1970; 39: 639-672.
4. Gerbitz, KD, Summer J, Schumacher I. Enolase isoenzymes as tumor markers. J Clin Chem Clin Biochem 1986; 24: 1009-1016.
5. Cooper EH. Neuron-specific enolase. Int J Biol Markers 1994; 9: 205-210.
6. Carney DN, Marangos PJ, Ihde DC, Bunn PA, Cohen MH, Minna JD, Gazdar AF. Serum neuron-specific Enolase: a marker for disease extent and response to therapy of small-cell lung cancer. Lancet 1982; 1: 583-585.
7. Pancholi V. Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci 2001; 58: 902-20.
8. Wistow G, Richardson J, Jaworski C, Graham C, Sharon-Friling R, Segovia L. Crystallins: the over -expression of functional enzymes and stress proteins in the eye lens. Biotechnol Genet Eng Rev 1994; 12: 1-38.
9. Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF. Role of cell-surface lysines in plas-minogen binding to cells: identification of alpha -enolase as a candidate plasminogen receptor. Biochemistry 1991; 30: 1682-1691.
10. Nakajima K, Hamanoue M, Takemoto N, Hattori T, Kato K, Kohsaka S. Plasminogen binds specifically to alpha-enolase on rat neuronal plasma membrane. J Neurochem 1994; 63: 2048-2057.
11. Dudani AK, Cummings C, Hashemi S, Ganz PR. Isolation of a novel 45 kDa plasminogen receptor from human endothelial cells. Thromb Res 1993; 69: 185-196.
12. Walsh JL, Keith TJ, Knull HR. Glycolytic enzyme interactions with tubulin and microtubules. Biochim Biophys Acta 1989; 999: 64-70.
13. Knull HR, Walsh JL. Association of glycolytic enzymes with the cytoskeleton. Curr Top Cell Regul 1992; 33: 15-30.
14. Johnstone SA, Waisman DM, Rattner JB. Enolase is present at the centrosome of HeLa cells. Exp Cell Res 1992; 202: 458-63.
15. Laberge RM, Ambadipudi R, Georges E. P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to vera-pamil Arch Biochem Biophys 2009; 49: 53-60.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacterio-phage T4. Nature 1970; 227: 680-685.
17. Towbin H, Staehelin T, Gordon J. Electropho-retic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-434.
18. Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nature Cancer Review 2011; 11: 85-95.
19. Aaronson RM, Graven KK, Tucci M, McDonald RJ, Farber HW. Non-neuronal enolase is an endothelial hypoxic stress protein. J Biol Chem 1995; 270: 27752-27757.
20. Graven KK, Farber HW. Endothelial cell hypoxic stress proteins. J Lab Clin Med 1998; 132: 456 -463.
21. Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994; 269: 23757-23763.
22. Forsyth JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. Mol Cell Biol 1996; 16: 4604-4613.
23. Ferrara N. VEGF: an update on biological and therapeutic aspects. Curr Opin Biotechnol 2000; 11: 617-24
24. Tran J, Master Z, Yu JL, Rak J, Dumont DJ, Ker-bel RS. A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc Natl Acad Sci 2002; 99: 4349-4354.
25. Kerbel RS, Yu J, Tran J, Man S, Viloria-Petit A, Klement G, Coomber BL, Rak J. Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches. Cancer & Metastasis Reviews 2001; 20: 79-86.
26. Gitlits VM, Toh BH, Loveland KL, Sentry JW. The glycolytic enzyme enolase is present in sperm tail and displays nucleotide-dependent association with microtubules. Eur J Cell Biol 2000; 79: 104-111.
27. Vertessy BG, Kovacs J, Low P, Lehotzky A, Molnar A, Orosz F, Ovadi J. Characterization of microtubule-phosphofructokinase complex: specific effects of MgATP and vinblastine. Biochemistry 1997; 36: 2051-2062.
28. Vertessy BG, Bankfalvi D, Kovacs J, Low P, Le-hotzky A, Ovadi, J. Pyruvate kinase as a micro-tubule destabilizing factor in vitro. Biochem Biophys Res Commun 1999; 254: 430-435.